Rapamycin decreases airway remodeling and hyperreactivity in a transgenic model of noninflammatory lung disease.
about
Differential effects of rapamycin and dexamethasone in mouse models of established allergic asthmaActivation of the mTOR signaling pathway is required for asthma onset.Secreted phosphoprotein 1 is a determinant of lung function development in mice.Senescent Cells Contribute to the Physiological Remodeling of Aged LungsMammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging.
P2860
Rapamycin decreases airway remodeling and hyperreactivity in a transgenic model of noninflammatory lung disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rapamycin decreases airway rem ...... noninflammatory lung disease.
@ast
Rapamycin decreases airway rem ...... noninflammatory lung disease.
@en
type
label
Rapamycin decreases airway rem ...... noninflammatory lung disease.
@ast
Rapamycin decreases airway rem ...... noninflammatory lung disease.
@en
prefLabel
Rapamycin decreases airway rem ...... noninflammatory lung disease.
@ast
Rapamycin decreases airway rem ...... noninflammatory lung disease.
@en
P2093
P2860
P1476
Rapamycin decreases airway rem ...... f noninflammatory lung disease
@en
P2093
Elizabeth L Kramer
Elizabeth M Mushaben
Gurjit Khurana Hershey
Jeffrey A Whitsett
Patricia A Pastura
Thomas H Acciani
Thomas R Korfhagen
William D Hardie
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00737.2011
P407
P577
2011-09-08T00:00:00Z